Press release
Cytomegalovirus (CMV) Infection Pipeline Assessment, 2024: FDA Approvals, Clinical Trials, Treatment Market, Therapies, MOA, ROA by DelveInsight | Merck Sharp & Dohme LLC, Chimerix, VBI Vaccines, Atara Biotherapeutics, SpyBiotech, Moderna, China Immunotec
Cytomegalovirus (CMV) Infection Pipeline
"Cytomegalovirus (CMV) Infection Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Cytomegalovirus (CMV) Infection Market.
The Cytomegalovirus (CMV) Infection Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.
Request for Sample Report @ https://www.delveinsight.com/sample-request/cytomegalovirus-cmv-infection-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Some of the key takeaways from the Cytomegalovirus (CMV) Infection Pipeline Report:
• CMV Infections Companies across the globe are diligently working toward developing novel Cytomegalovirus (CMV) Infection treatment therapies with a considerable amount of success over the years.
• Cytomegalovirus (CMV) Infection companies working in the treatment market are antiviral therapeutics TSRL, Synklino, AlloVir, Moderna, China Immunotech, Nobelpharma, Hookipa Biotech GmbH, Biotest, AlloVir, VBI Vaccines, Lion TCR, Shire, Merck Sharp & Dohme, Takeda, CSL Behring, Chimerix, Novartis, Hookipa Biotech GmbH, and others, are developing therapies for the Cytomegalovirus (CMV) Infection treatment
• Emerging Cytomegalovirus (CMV) Infection therapies in the different phases of clinical trials are- Research programme, SYN002, Posoleucel, mRNA-1647, CMV TCR T cell therapy, NPC-21, HB-101, Cytomegalovirus immune globulin, Posoleucel, VBI-1501A, LTV 20, Maribavir, V160, Maribavir, Valganciclovir, Brincidofovir, Everolimus, HB-101 vaccine, and others are expected to have a significant impact on the Cytomegalovirus (CMV) Infection market in the coming years.
• In June 2023, The FDA sanctioned letermovir for shielding adult kidney transplant recipients at elevated risk (where the donor has CMV antibodies and the recipient does not). Letermovir, a novel non-nucleoside medication, is the first of its kind designed to impede viral replication by specifically targeting the viral terminase complex.
Cytomegalovirus (CMV) Infection Overview
Cytomegalovirus (CMV) is a common virus belonging to the herpesvirus family. While it usually causes mild symptoms or none at all in healthy individuals, it can pose serious risks to unborn babies and people with weakened immune systems. CMV is spread through bodily fluids like saliva, blood, urine, and breast milk, as well as through sexual contact and organ transplantation.
Symptoms of CMV infection can include fever, fatigue, sore throat, swollen glands, and muscle aches, though many infected individuals may not show any symptoms. In pregnant women, CMV can lead to congenital disabilities or developmental delays in the baby if the virus is transmitted from mother to fetus.
Cytomegalovirus (CMV) Infection Diagnosis typically involves blood tests to detect antibodies or the virus itself. While there's no specific treatment for CMV, antiviral medications can help manage symptoms and reduce the severity of the infection, particularly in immunocompromised individuals.
Cytomegalovirus (CMV) Infection Prevention focuses on practicing good hygiene, especially around young children and pregnant women, and avoiding contact with bodily fluids from infected individuals. Additionally, pregnant women should undergo routine screening for CMV to monitor for potential transmission to the fetus.
Get a Free Sample PDF Report to know more about Cytomegalovirus (CMV) Infection Pipeline Therapeutic Assessment-
https://www.delveinsight.com/report-store/cytomegalovirus-cmv-infection-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Emerging Cytomegalovirus (CMV) Infection Drugs Under Different Phases of Clinical Development Include:
• Research programme: antiviral therapeutics TSRL
• SYN002: Synklino
• Posoleucel: AlloVir
• mRNA-1647: Moderna
• CMV TCR T cell therapy: China Immunotech
• NPC-21: Nobelpharma
• HB-101: Hookipa Biotech GmbH
• Cytomegalovirus immune globulin: Biotest
• Posoleucel: AlloVir
• VBI-1501A: VBI Vaccines
• LTV 20: Lion TCR
• Maribavir: Shire
• V160: Merck Sharp & Dohme
• Maribavir: Takeda
• Valganciclovir: CSL Behring
• Brincidofovir: Chimerix
• Everolimus: Novartis
• HB-101 vaccine: Hookipa Biotech GmbH
Cytomegalovirus (CMV) Infection Route of Administration
Cytomegalovirus (CMV) Infection pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as
• Intranasal
• Intrathecal
• Intravenous
• Oral
• Oral/Intravenous
• Parenteral
• Subcutaneous
• Subcutaneous/Intramuscular
• Transdermal
Cytomegalovirus (CMV) Infection Molecule Type
Cytomegalovirus (CMV) Infection Products have been categorized under various Molecule types, such as
• Antisense oligonucleotide
• Gene therapy
• Hormones
• Neuropeptides
• Oligonucleotides
• Small Molecule
• Triglyceride
Cytomegalovirus (CMV) Infection Pipeline Therapeutics Assessment
• Cytomegalovirus (CMV) Infection Assessment by Product Type
• Cytomegalovirus (CMV) Infection By Stage and Product Type
• Cytomegalovirus (CMV) Infection Assessment by Route of Administration
• Cytomegalovirus (CMV) Infection By Stage and Route of Administration
• Cytomegalovirus (CMV) Infection Assessment by Molecule Type
• Cytomegalovirus (CMV) Infection by Stage and Molecule Type
DelveInsight's Cytomegalovirus (CMV) Infection Pipeline Report covers around 20+ products under different phases of clinical development like
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
• Route of Administration
Further Cytomegalovirus (CMV) Infection product details are provided in the report. Download the Cytomegalovirus (CMV) Infection pipeline report to learn more about the emerging Cytomegalovirus (CMV) Infection therapies at:
https://www.delveinsight.com/sample-request/cytomegalovirus-cmv-infection-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Some of the key companies in the Cytomegalovirus (CMV) Infection Therapeutics Market include:
Key companies developing therapies for Cytomegalovirus (CMV) Infection are - Merck Sharp & Dohme LLC, Chimerix, VBI Vaccines, Atara Biotherapeutics, SpyBiotech, Moderna, China Immunotech, Nobelpharma, Hookipa Biotech GmbH, Biotest, AlloVir, and others.
Cytomegalovirus (CMV) Infection Pipeline Analysis:
The Cytomegalovirus (CMV) Infection pipeline report provides insights into
• The report provides detailed insights about companies that are developing therapies for the treatment of Cytomegalovirus (CMV) Infection with aggregate therapies developed by each company for the same.
• It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Cytomegalovirus (CMV) Infection Treatment.
• Cytomegalovirus (CMV) Infection key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• Cytomegalovirus (CMV) Infection Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Cytomegalovirus (CMV) Infection market.
The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.
Download Sample PDF Report to know more about Cytomegalovirus (CMV) Infection drugs and therapies-
https://www.delveinsight.com/sample-request/cytomegalovirus-cmv-infection-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Cytomegalovirus (CMV) Infection Pipeline Market Drivers
• Increasing Prevalence of Cytomegalovirus (CMV) Infection, increase in Research and developmental Activities are some of the important factors that are fueling the Cytomegalovirus (CMV) Infection Market.
Cytomegalovirus (CMV) Infection Pipeline Market Barriers
• However, high costs associated with the treatment, lack of healthcare infrastructures and other factors are creating obstacles in the Cytomegalovirus (CMV) Infection Market growth.
Scope of Cytomegalovirus (CMV) Infection Pipeline Drug Insight
• Coverage: Global
• Key Cytomegalovirus (CMV) Infection Companies: antiviral therapeutics TSRL, Synklino, AlloVir, Moderna, China Immunotech, Nobelpharma, Hookipa Biotech GmbH, Biotest, AlloVir, VBI Vaccines, Lion TCR, Shire, Merck Sharp & Dohme, Takeda, CSL Behring, Chimerix, Novartis, Hookipa Biotech GmbH, and others
• Key Cytomegalovirus (CMV) Infection Therapies: Research programme, SYN002, Posoleucel, mRNA-1647, CMV TCR T cell therapy, NPC-21, HB-101, Cytomegalovirus immune globulin, Posoleucel, VBI-1501A, LTV 20, Maribavir, V160, Maribavir, Valganciclovir, Brincidofovir, Everolimus, HB-101 vaccine, and others
• Cytomegalovirus (CMV) Infection Therapeutic Assessment: Cytomegalovirus (CMV) Infection current marketed and Cytomegalovirus (CMV) Infection emerging therapies
• Cytomegalovirus (CMV) Infection Market Dynamics: Cytomegalovirus (CMV) Infection market drivers and Cytomegalovirus (CMV) Infection market barriers
Request for Sample PDF Report for Cytomegalovirus (CMV) Infection Pipeline Assessment and clinical trials-
https://www.delveinsight.com/sample-request/cytomegalovirus-cmv-infection-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Table of Contents
1. Cytomegalovirus (CMV) Infection Report Introduction
2. Cytomegalovirus (CMV) Infection Executive Summary
3. Cytomegalovirus (CMV) Infection Overview
4. Cytomegalovirus (CMV) Infection- Analytical Perspective In-depth Commercial Assessment
5. Cytomegalovirus (CMV) Infection Pipeline Therapeutics
6. Cytomegalovirus (CMV) Infection Late Stage Products (Phase II/III)
7. Cytomegalovirus (CMV) Infection Mid Stage Products (Phase II)
8. Cytomegalovirus (CMV) Infection Early Stage Products (Phase I)
9. Cytomegalovirus (CMV) Infection Preclinical Stage Products
10. Cytomegalovirus (CMV) Infection Therapeutics Assessment
11. Cytomegalovirus (CMV) Infection Inactive Products
12. Company-University Collaborations (Licensing/Partnering) Analysis
13. Cytomegalovirus (CMV) Infection Key Companies
14. Cytomegalovirus (CMV) Infection Key Products
15. Cytomegalovirus (CMV) Infection Unmet Needs
16 . Cytomegalovirus (CMV) Infection Market Drivers and Barriers
17. Cytomegalovirus (CMV) Infection Future Perspectives and Conclusion
18. Cytomegalovirus (CMV) Infection Analyst Views
19. Appendix
20. About DelveInsight
Trending Reports:
• 3d Cardiac Mapping System Market: https://www.delveinsight.com/report-store/3d-cardiac-mapping-system-market
• Acute Pulmonary Embolism Market: https://www.delveinsight.com/report-store/acute-pulmonary-embolism-market
• Aortic Stenosis Market: https://www.delveinsight.com/report-store/aortic-stenosis-market
• Bile Duct Neoplasm Market: https://www.delveinsight.com/report-store/bile-duct-neoplasms-market
• Carcinoid Tumor Market: https://www.delveinsight.com/report-store/carcinoid-tumor-market
• Cluster Headache Market: https://www.delveinsight.com/report-store/cluster-headache-market
• Condyloma Market: https://www.delveinsight.com/report-store/condyloma-market
• Familial Primary Pulmonary Hypertension Market: https://www.delveinsight.com/report-store/familial-primary-pulmonary-hypertension-market
• Fibrocystic Breast Condition Market: https://www.delveinsight.com/report-store/fibrocystic-breast-condition-market
• Meningioma Market: https://www.delveinsight.com/report-store/meningioma-market
• Progressive Multifocal Leukoencephalopathy Market: https://www.delveinsight.com/report-store/progressive-multifocal-leukoencephalopathy-market
• Rhino Conjunctivitis Market: https://www.delveinsight.com/report-store/rhino-conjunctivitis-market
• Ventilator Market: https://www.delveinsight.com/report-store/ventilators-market
• Intracranial Pressure Monitoring Devices Market: https://www.delveinsight.com/report-store/intracranial-pressure-monitoring-devices-market
• Hemodynamic Monitoring Systems Market: https://www.delveinsight.com/report-store/hemodynamic-monitoring-system-market
• Automated External Defibrillators Market: https://www.delveinsight.com/report-store/automated-external-defibrillator-aed-market
• Neurostimulation Devices Market: https://www.delveinsight.com/report-store/neurostimulation-devices-market
• Neuroprosthetics Market: https://www.delveinsight.com/blog/neuroprosthetics-market-analysis
• Eczema Market: https://www.delveinsight.com/report-store/eczema-market
• Foot And Ankle Devices Market: https://www.delveinsight.com/report-store/foot-and-ankle-devices-market
• Neuroblastoma Market: https://www.delveinsight.com/report-store/neuroblastoma-market
• Pharmaceutical Consulting Companies: https://www.delveinsight.com/consulting
• Allergic Conjunctivitis Market: https://www.delveinsight.com/report-store/allergic-conjunctivitis-market
• Biotech Consulting: https://www.delveinsight.com/consulting
• Cervical Intraepithelial Neoplasia Market: https://www.delveinsight.com/report-store/cervical-cancer-market
• Osteoarthritis Market: https://www.delveinsight.com/report-store/osteoarthritis-market
• Pruritus Market: https://www.delveinsight.com/report-store/cholestatic-pruritus-market
• Capnography Device Market: https://www.delveinsight.com/report-store/capnography-devices-market
• Image Guided Surgery Devices Market: https://www.delveinsight.com/report-store/image-guided-surgery-devices-market
• Opioid Induced Constipation Market: https://www.delveinsight.com/report-store/opioid-induced-constipation-market
• Alzheimer Disease Market: https://www.delveinsight.com/report-store/alzheimers-disease-ad-market
• Angioedema Market: https://www.delveinsight.com/report-store/angioedema-market
• Neurovascular Devices Market: https://www.delveinsight.com/report-store/neurovascular-devices-interventional-neurology-market
• Actinic Keratosis Market: https://www.delveinsight.com/report-store/actinic-keratosis-market
• Acute Coronary Syndrome Market: https://www.delveinsight.com/report-store/acute-coronary-syndrome-market
• Blood Gas And Electrolyte Analyzers Market: https://www.delveinsight.com/report-store/blood-gas-and-electrolyte-analyzers-market
Contact Us:
Ankit Nigam
info@delveinsight.com
+14699457679
https://www.delveinsight.com/consulting
About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cytomegalovirus (CMV) Infection Pipeline Assessment, 2024: FDA Approvals, Clinical Trials, Treatment Market, Therapies, MOA, ROA by DelveInsight | Merck Sharp & Dohme LLC, Chimerix, VBI Vaccines, Atara Biotherapeutics, SpyBiotech, Moderna, China Immunotec here
News-ID: 3477051 • Views: …
More Releases from DelveInsight Business Research
Pharma Asset Management Success Story: Strategic In-Licensing in the Atrial Fibr …
DelveInsight, a leading business consulting and market research firm, is pleased to announce the successful completion of an Asset Prioritization project that enabled a mid-sized pharmaceutical client to identify, evaluate, and secure a high-value therapeutic asset for in-licensing in the Atrial Fibrillation (AF) space. The case study highlights how evidence-based insights, structured methodologies, and multi-layered evaluations supported the client in achieving its long-term strategic growth goals.
Objective of the Case Study
The…
Myopia Clinical Trials Outlook 2025: Competitive Landscape, Regulatory Milestone …
(Albany, USA) - DelveInsight's newly released report, "Myopia Pipeline Insight 2025," delivers an in-depth assessment of the clinical trial landscape, regulatory progress, and therapeutic development trends shaping the Myopia therapeutics market. The analysis highlights ongoing clinical advancements, pipeline opportunities, and the potential impact of emerging therapies on patient care and market dynamics.
According to DelveInsight's evaluation, the Myopia pipeline remains highly active, with 8+ pharmaceutical and biotechnology companies investigating more than…
Global Biopsy Devices Market to Reach USD 10.81 Billion by 2032, Driven by Risin …
The global biopsy devices market is poised for significant growth, with market size projected to increase from USD 5,813.16 million in 2024 to USD 10,812.77 million by 2032, expanding at a CAGR of 8.09% during 2025-2032. The robust expansion is being driven by the growing incidence of cancers, rising demand for minimally invasive diagnostic procedures, and rapid advancements in biopsy technologies.
Biopsy devices play a crucial role in disease diagnosis by…
Global General Surgery Devices Market to Reach USD 35.4 Billion by 2032, Driven …
According to the latest market analysis, the global general surgery devices market is set for robust growth, increasing from USD 21,786.29 million in 2024 to USD 35,399.63 million by 2032, expanding at a CAGR of 6.34% during 2025-2032. This growth reflects a surge in surgical procedures, continuous technological advancements, and rising demand for minimally invasive and robotic-assisted surgical techniques across healthcare systems worldwide.
DelveInsight's General Surgery Devices Market Report 2032 provides…
More Releases for CMV
Cytomegalovirus (CMV) Infections Market Massive Growth opportunity Ahead
Introduction
Cytomegalovirus (CMV) is a common herpesvirus that affects people worldwide, often remaining latent in the body and reactivating under immunocompromised conditions. While typically asymptomatic in healthy individuals, CMV can cause severe complications in newborns, transplant recipients, and immunocompromised patients, making it a significant global healthcare burden.
With increasing awareness, advances in antiviral therapies, vaccines under development, and transplant-related CMV management, the CMV infections market is experiencing strong growth. The integration of…
Cytomegalovirus (CMV) Vaccine Market | Exploring Current Trends and Growth Statu …
Cytomegalovirus (CMV) Vaccine Market Outlook and Investment Analysis
What is the current outlook for the Cytomegalovirus (CMV) vaccine market?
The CMV vaccine market is seeing positive growth due to the increasing prevalence of CMV infections globally, particularly in immunocompromised populations such as organ transplant recipients and HIV patients. Moreover, the growing awareness of CMV's impact on newborns has contributed to the push for preventive vaccines. A few vaccines are in advanced clinical…
Cytomegalovirus (CMV) Test Market to Develop Rapidly by 2026
Cytomegalovirus (CMV) is a common virus that occurs widely among the population. In the U.S., 50%-85% of adults have been infected with cytomegalovirus (CMV). Most people who are infected with the virus do not experience any significant symptoms or health problems. CMV testing involves either a measurement of cytomegalovirus antibodies, immune proteins produced in response to CMV exposure, or the detection of the virus itself. CMV is found in many…
Global Commercial Cooking Device Market Forecast 2018-2025 CMV Sharper Finish, Q …
Market study on Global Commercial Cooking Device 2018 Research Report presents a professional and complete analysis of Global Commercial Cooking Device Market on the current market situation.
Report provides a general overview of the Commercial Cooking Device industry 2018 including definitions, classifications, Commercial Cooking Device market analysis, a wide range of applications and Commercial Cooking Device industry chain structure. The 2018's report on Commercial Cooking Device industry offers the global…
Cytomegalovirus (CMV) Market: Size, Status, Opportunity Analysis and Forecasts t …
A new independent 162 page research with title 'Cytomegalovirus (CMV): Opportunity Analysis and Forecasts to 2027' guarantees you will remain better informed than your competition. The study covers geographic analysis that includes regions like North America, Europe or Asia and important players/vendors such as Atara Bio, Biotest AG, Helocyte, Merck & Co., Novartis, Shire, ViraCyte With n-number of tables and figures examining the Cytomegalovirus (CMV) Market, the research gives…
Cytomegalovirus (CMV) Infection Treatment and Diagnosis Market Opportunity Analy …
Cytomegalovirus (CMV) is a virus that belongs to herpes virus family that remain dormant in the human body. CMV infection can occur in people of all ages worldwide. CMV is a communicable disease that spreads through body fluids such as saliva, blood, urine, semen, and breast milk. Presence of CMV infection can be detected by various testing methods based on which the global cytomegalovirus infection treatment and diagnosis market can…
